Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 04 2024 - 4:01PM
Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused
biopharmaceutical company, today announced that the company will
present at the 23rd Annual Needham (Virtual) Healthcare Conference
taking place April 8-11, 2024.
Company Fireside Chat Presentation
Details:
Date: |
Thursday, April 11, 2024 |
|
|
Time: |
3:00 PM Eastern Time |
|
|
Webcast: |
Register here |
|
|
Presenters: |
Ian Mortimer, President and Chief
Executive Officer |
|
Sherry Aulin, Chief Financial
Officer |
|
|
A live webcast of the company presentation will
be available on the “Investors” section of Xenon's website and
posted for replay following the event. The above listed dates and
times are subject to change.
About Xenon Pharmaceuticals
Inc.
Xenon Pharmaceuticals (Nasdaq:XENE) is a
neuroscience-focused biopharmaceutical company committed to
discovering, developing, and commercializing innovative
therapeutics to improve the lives of people living with
neurological and psychiatric disorders. We are advancing a novel
product pipeline to address areas of high unmet medical need,
including epilepsy and depression. For more information, please
visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered
trademarks or trademarks of Xenon Pharmaceuticals Inc. in various
jurisdictions. All other trademarks belong to their respective
owner.
Contacts: For Investors:Chad
FugereVice President, Investor Relations(857)
675-7275investors@xenon-pharma.com
For Media:Jodi RegtsXenon Corporate Affairs(604)
484-3353media@xenon-pharma.com
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From Apr 2024 to May 2024
Xenon Pharmaceuticals (NASDAQ:XENE)
Historical Stock Chart
From May 2023 to May 2024